Akihiro Koube

Akihiro Koube is a notable inventor based in Kikuyo-Machi, Japan. He has made significant contributions to the field of biologics, particularly in the development of vaccines and monoclonal antibodies. With a total of three patents to his name, Koube's work is focused on enhancing immune responses against viral infections.

Latest Patents

Koube's latest patents include a modified CMV gB protein and a CMV vaccine that utilizes this protein. The invention aims to provide a modified CMV gB protein capable of inducing a robust immune response, including a high ratio of neutralizing antibodies. This innovation is crucial for the prevention and treatment of cytomegalovirus (CMV) infections. Another significant patent involves an anti-HSV gB monoclonal antibody, which specifically targets the herpes simplex virus envelope glycoprotein B. This antibody is designed with specific amino acid sequences that enhance its binding efficacy.

Career Highlights

Koube is currently associated with Km Biologics Co., Ltd., where he continues to advance his research in the field of immunology. His work has been instrumental in developing therapeutic solutions that address viral infections, showcasing his commitment to public health.

Collaborations

Koube collaborates with esteemed colleagues such as Hiroaki Mori and Tomohiro Nishimura. Their combined expertise contributes to the innovative research and development efforts at Km Biologics Co., Ltd.

Conclusion

Akihiro Koube's contributions to the field of biologics through his patents and collaborative efforts highlight his role as a leading inventor in vaccine development. His work is paving the way for advancements in the prevention and treatment of viral infections.

Profile summary based on public USPTO records.